Stock Watch 9.21.11 ” Resurrecting the Rejected” OREX is attempting to resurrect it’s failed weight loss drug Contrave. This jibber sent the stock to the moon after hours with an 90% gain. That stock is in play big time for Wednesday along with it’s weight loss compatriots VVUS and ARNA. Full write up here http://www.thestreet.com/story/11254293/1/orexigen-resurrects-rejected-obesity-drug.html?cm_ven=GOOGLEN The […]
